Should the Portal Vein Be Routinely Resected During Pancreaticoduodenectomy For Adenocarcinoma?
- 1 April 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 257 (4), 726-730
- https://doi.org/10.1097/sla.0b013e318269d23c
Abstract
In pancreatic adenocarcinoma (PA), a margin negative resection (R0) is critical for long-term survival. Although pancreaticoduodenectomy (PD) with en-bloc portal vein/superior mesenteric vein (PV/SMV) resection is used in patients with venous involvement by tumor, its utility in patients with no venous involvement is unknown. This study examines survival in patients with no venous involvement who had PD with PV/SMV resection. From 2000 to 2010, 34 patients had PD with PV/SMV resection for resectable PA on preoperative staging. Fifteen patients (44%) had histological venous involvement and 19 (56%) had no histological involvement (-PV/SMV group). We matched 1:1 the -PV/SMV group (n = 19) with 19 contemporaneous PA patients who had a standard PD (control group) for age, tumor stage, tumor size, lymph node invasion, lymph node ratio, perineural invasion, margins status, and carbohydrate antigen 19-9 (CA 19-9) levels. No differences were noted between the -PV/SMV group (n = 19) and the matched control group (n = 19) in morbidity, mortality, reoperation rate, or length of hospital stay. Median survival (42 months vs. 22 months, P = 0.02) and overall 3-year survival (60% vs. 31%, P = 0.03) were significantly longer in the -PV/SMV group compared with the control group. Patients with PA and no venous involvement who had PD with PV/SMV resection had a significantly longer overall survival than patients in a matched control group who had PD without venous resection.Keywords
This publication has 26 references indexed in Scilit:
- Vascular Resection in Pancreatic Cancer Surgery: Survival DeterminantsJournal of Gastrointestinal Surgery, 2009
- Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at PancreaticoduodenectomyAnnals of Surgery, 2008
- Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal AdenocarcinomaPancreas, 2008
- Portal Vein Resection in Surgery for Cancer of Biliary Tract and Pancreas: Special Reference to the Relationship Between the Surgical Outcome and Site of Primary TumorJournal of Gastrointestinal Surgery, 2008
- New Concepts in Staging and Treatment of Locally Advanced Pancreatic Head CancerAmerican Journal of Roentgenology, 2007
- The Role of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer: Systematic Review of Randomized Controlled Trials and Meta-AnalysisOncology, 2007
- A Margin-Negative R0 Resection Accomplished With Minimal Postoperative Complications Is the Surgeon's Contribution to Long-Term Survival in Pancreatic CancerJournal of Gastrointestinal Surgery, 2006
- Postoperative Morbidity and Long-term Survival After Pancreaticoduodenectomy With Superior Mesenterico−Portal Vein ResectionJournal of Gastrointestinal Surgery, 2006
- Pancreaticoduodenectomy with Mesentericoportal Vein Resection for Adenocarcinoma of the Pancreatic HeadWorld Journal of Surgery, 2006
- Pancreaticoduodenectomy with En Bloc Portal Vein Resection for Pancreatic Carcinoma with Suspected Portal Vein InvolvementWorld Journal of Surgery, 2004